Compound Evidence File
#EC-2026-0907
Anastrozole (Arimidex) Raw
Filed under Raw Materials. The bureau holds 138 laboratory returns for this compound from 43 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
43 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 10.0 | 9.9 | 10.0 | 22 Feb 2026 | 3 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 10.0 | 10.0 | 10.0 | 10 Feb 2026 | 3 Apr 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 9.9 | 10.0 | 10 Dec 2025 | 9 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 10.0 | 10.0 | 10.0 | 5 Mar 2026 | 26 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 10.0 | 9.9 | 10.0 | 13 Feb 2026 | 9 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 10.0 | 10.0 | 28 Jan 2026 | 6 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 10.0 | 10.0 | 10.0 | 8 Feb 2026 | 1 May 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 9.9 | 10.0 | 12 Jun 2026 | 18 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 10.0 | 10.0 | 10.0 | 5 Mar 2026 | 24 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 10.0 | 10.0 | 10.0 | 6 Jan 2026 | 26 Feb 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 10.0 | 10.0 | 10.0 | 3 Jun 2026 | 26 Jun 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 10.0 | 10.0 | 10.0 | 2 Jun 2026 | 8 Jul 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 9.9 | 9.9 | 9.9 | 25 May 2026 | 25 May 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 10.0 | 1 Dec 2025 | 15 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 9.9 | 9.9 | 10.0 | 23 May 2026 | 5 Aug 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 9.9 | 9.9 | 10.0 | 18 Jan 2026 | 17 Aug 2026 |
| SinoPepCASE #VI-2026-0387 | A | 4 | 9.9 | 9.9 | 10.0 | 6 Apr 2026 | 25 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 9.9 | 9.9 | 10.0 | 11 Jan 2026 | 16 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 9.9 | 9.9 | 10.0 | 14 May 2026 | 3 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 9.9 | 9.9 | 10.0 | 18 Mar 2026 | 25 Apr 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 9.9 | 9.9 | 10.0 | 11 Mar 2026 | 21 May 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 18 Jul 2026 | 21 Jul 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 7 | 8.7 | 7.8 | 9.8 | 25 May 2026 | 25 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 8.7 | 8.3 | 9.5 | 24 May 2026 | 24 May 2026 |
| Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 | X | 1 | 8.7 | 8.7 | 8.7 | 2 Apr 2025 | 2 Apr 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 5 | 8.6 | 7.6 | 10.0 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 8.4 | 7.6 | 9.7 | 24 May 2026 | 24 May 2026 |
| Golden EagleCASE #VI-2026-0680 | X | 1 | 8.4 | 8.4 | 8.4 | 6 May 2025 | 6 May 2025 |
| NextGen HealthCASE #VI-2026-0604 | X | 1 | 8.3 | 8.3 | 8.3 | 7 May 2025 | 7 May 2025 |
| Zen PeptidesCASE #VI-2026-0940 | X | 1 | 8.3 | 8.3 | 8.3 | 25 Apr 2025 | 25 Apr 2025 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | X | 7 | 7.9 | 7.1 | 9.0 | 13 Feb 2025 | 17 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 4 | 7.8 | 7.2 | 8.7 | 21 May 2026 | 21 May 2026 |
| BeiBangAnCASE #VI-2026-0899 | X | 3 | 7.6 | 5.4 | 9.8 | 9 Jun 2025 | 23 May 2026 |
| Atomik LabzCASE #VI-2026-0327 | X | 4 | 7.4 | 6.7 | 8.2 | 17 Dec 2024 | 23 May 2026 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 7.3 | 7.3 | 7.3 | 20 Jun 2025 | 20 Jun 2025 |
| Qingdao Hongshengda TradingCASE #VI-2026-0334 | X | 1 | 6.6 | 6.6 | 6.6 | 8 Jul 2025 | 8 Jul 2025 |
| Pura PeptidesCASE #VI-2026-0307 | X | 1 | 6.1 | 6.1 | 6.1 | 20 Jun 2025 | 20 Jun 2025 |
| Qing Li PeptideCASE #VI-2026-0469 | X | 9 | 6.0 | 3.6 | 8.4 | 25 Apr 2025 | 23 May 2026 |
| Mix PeptidesCASE #VI-2026-0699 | X | 1 | 5.0 | 5.0 | 5.0 | 14 Jan 2025 | 14 Jan 2025 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | X | 1 | 3.7 | 3.7 | 3.7 | 17 Dec 2024 | 17 Dec 2024 |
| Wolverine PeptidesCASE #VI-2026-0262 | X | 1 | 3.2 | 3.2 | 3.2 | 2 Apr 2025 | 2 Apr 2025 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 2.2 | 2.2 | 2.2 | 16 Mar 2025 | 16 Mar 2025 |
Open any subject to view the batch-level evidence for Anastrozole (Arimidex) Raw alone.